Discovery and biochemical characterization of selective ATP competitive inhibitors of the human mitotic kinesin KSP
Keith Rickert(United States Military Academy), Carolyn A. Buser(United States Military Academy), Diane Harvey(United States Military Academy), Yun Zhang(Kunming Institute of Zoology), Paul J. Coleman(Merck & Co., Inc., Rahway, NJ, USA (United States)), Lou Anne Neilson(United States Military Academy), Gary T. Marshall(United States Military Academy), Yi Yang(Shandong University), Kelly Hamilton(United States Military Academy), Eileen S. Walsh(United States Military Academy), R. M. Garbaccio(Merck & Co., Inc., Rahway, NJ, USA (United States)), Maricel Torrent(United States Military Academy), Ling Lee(United States Military Academy), Michael D. Schaber(United States Military Academy), Edward S. Tasber(United States Military Academy)
Cited by 50
Related Papers
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
|Nature|2017|853
The importance of synthetic chemistry in the pharmaceutical industry
|Science|2019|650
CC-1065 and the Duocarmycins: Synthetic Studies
|Chemical Reviews|1997|267
Kinesin Spindle Protein (KSP) Inhibitors. 9. Discovery of (2<i>S</i>)-4-(2,5-Difluorophenyl)-<i>N</i>-[(3<i>R</i>,4<i>S</i>)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-<i>N</i>-methyl-2-phenyl-2,5-dihydro-1<i>H</i>-pyrrole-1-carboxamide (MK-0731) for the Treatment of Taxane-Refractory Cancer
|Journal of Medicinal Chemistry|2008|156